Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome.

Ofran, Yishay

Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome. [electronic resource] - American journal of hematology Apr 2007 - 332-3 p. digital

Publication Type: Case Reports; Letter

0361-8609

10.1002/ajh.20773 doi


Antineoplastic Agents--adverse effects
Arsenic Trioxide
Arsenicals--adverse effects
Cell Differentiation--drug effects
Humans
Male
Middle Aged
Myelodysplastic Syndromes--drug therapy
Oxides--adverse effects
Pulmonary Alveoli--drug effects
Respiratory Distress Syndrome--chemically induced
Syndrome